Survey Presented at the Joint Annual Meeting of the International Congress of Endocrinology and The Endocrine Society (ICE/ENDO 2014) Shows Most of Those Affected by Obesity are Not Taking Steps to Lose Weight
Those Who Take Steps Report Greater Satisfaction with Weight Loss Medications and Surgical Procedures

WOODCLIFF LAKE, N.J., June 23, 2014 /PRNewswire/ -- An analysis of data from the 2012 U.S. National Health and Wellness Survey showed that the majority of those affected by obesity are not taking steps to lose weight (58.4%). The analysis of more than 71,157 respondents, including approximately 23,000 adults with obesity, was conducted by Eisai Inc. and Kantar Health and results were highlighted as part of an official news conference at the 16th International Congress of Endocrinology and The Endocrine Society's 96th Annual Meeting and Expo (ICE/ENDO 2014) in Chicago, Ill. 

Eisai logo

The survey also revealed that among those who did take measures to lose weight, prescription weight loss medications and surgical procedures yielded greater satisfaction (39.3%), measured by the percentage of respondents who reported they were extremely or very satisfied with treatment, versus self-modification methods alone such as diet, exercise and weight management programs (20.2%).

"These findings show that diet and exercise alone may not work for a lot of people and identifying methods that lead to greater satisfaction may help get people on track for achieving and maintaining long-term weight loss," said Z. Jason Wang, PhD, the study's principal investigator and Director of Health Economics and Outcomes Research at Eisai Inc.

"Eisai is committed to advancing knowledge about the treatment of obesity, a chronic, progressive disease that has serious health consequences," added Gary Palmer, Chief Medical Officer and Vice President, Medical Affairs at Eisai Inc. "The results of the survey suggest the need for more education on the health effects of obesity and available treatment options and underscore the importance of physicians needing to have a dialogue with patients to determine the most appropriate weight loss plan for them."

About Eisai Inc.

At Eisai Inc., human health care is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities. Our key areas of commercial focus include oncology and specialty care (Alzheimer's disease, epilepsy and metabolic disorders). To learn more about Eisai Inc., please visit us at www.eisai.com/US

Eisai Inc. has affiliates that are part of a global product creation organization that includes R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as a global demand chain organization that includes manufacturing facilities in Maryland and North Carolina. Eisai's global areas of R&D focus include neuroscience; oncology; metabolic disorders; vascular, inflammatory and immunological reaction; and antibody-based programs.

Media Inquiries

Investor Inquiries

Laurie Landau

Alex Scott

Eisai Inc.

Eisai Inc.

(201) 746-2510

(201) 746-2177

Laurie_Landau@eisai.com

Alex_Scott@eisai.com

Logo - http://photos.prnewswire.com/prnh/20120413/MM87168LOGO 

SOURCE Eisai Inc.

Type Press Release

Date Released June 23, 2014

RECENT RELEASES
Apr 19, 2021

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Michel Vounatsos, "Biogen") today announced...

Apr 16, 2021

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today that data from the company's deep neurology pipeline and portfolio, including Alzheimer's disease, insomnia and...

Apr 11, 2021

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced that its animation “Leave No One Behind-Disease of Neglected People” which features activities for the...

Alerts - Release page
SUBSCRIBE TO OUR NEWS
* Required Fields